Dr. Karl Erick Haglund, MD, PhD

Dr. Haglund practices at OSU Radiation Oncology in Columbus, Ohio.

Dr. Haglund's NPI, 1518093996, was assigned on February 27, 2007. Dr. Haglund graduated from Yale University School of Medicine in 2004. Dr. Haglund holds Ohio license 35121832.

Dr. Haglund's primary practice is OSU Radiation Oncology, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-8415.

Dr. Haglund's primary practice is OSU Radiation Oncology in Columbus, Ohio. Dr. Haglund is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Haglund to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haglund practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Haglund's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Haglund is licensed in Ohio.

CMS data shows 692 Medicare services from Dr. Haglund across 12 procedure codes in 2024, for 111 Medicare patients. Medicare paid $59,090 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Dr. Haglund in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haglund's median patient age at 70, with 44% women.

In 2024, Dr. Haglund wrote 25 Medicare Part D claims for 12 patients. 96% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $280 in total drug cost. In 2019, CMS named 40 claims across 2 drugs.

Dr. Haglund accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haglund as offering telehealth.

Dmand AI links 17 papers to Dr. Haglund, published from 2014 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Radiosurgery. Dr. Haglund has published most often in Int J Radiat Oncol Biol Phys. Dr. Haglund's most frequent co-authors are Terence Williams, MD, John C. Grecula, MD and Jose Gilberto Bazan, MD.

Dmand AI links Dr. Haglund to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Carcinoma, Bronchogenic.

CMS Open Payments shows 1 general payment to Dr. Haglund from 1 drug or device company in 2019. Education make up the largest share, 100% of the total. Novocure Inc. paid the most, $13. It also lists 10 research payments totaling $1,481 in 2019.

Dr. Haglund graduated from Yale University School of Medicine in 2004.